Genotyping circulating rotaviruses before and after introduction of rotavirus vaccine is useful for evaluating vaccine-associated changes in genotype distribution. We determined frequency of rotavirus genotypes among 61 rotavirus-positive children hospitalized in Israel during the 2005-06 rotavirus season. Accurate molecular epidemiologic data were recovered from affi nity-concentrated rotavirus immobilized in rotavirus-positive bands from air-dried, diagnostic rotavirus rapid test strips (dipstick) stored at room temperature from 1 week to 5 years. G genotypes were identical for 21 paired dipsticks and suspensions, whereas dipsticks or suspensions detected an additional G genotype in 2 samples. RNA sequences from 7 pairs were identical. Phylogenetic analysis suggested previously unreported G2 sublineages and G9 lineages. The ease with which dipsticks can be stored at local facilities and transported to central reference laboratories can reverse increasing diffi culties in obtaining geographically representative stool samples and expand surveillance to regions lacking adequate laboratory facilities.
Genotyping circulating rotaviruses before and after introduction of rotavirus vaccine is useful for evaluating vaccine-associated changes in genotype distribution. We determined frequency of rotavirus genotypes among 61 rotavirus-positive children hospitalized in Israel during the 2005-06 rotavirus season. Accurate molecular epidemiologic data were recovered from affi nity-concentrated rotavirus immobilized in rotavirus-positive bands from air-dried, diagnostic rotavirus rapid test strips (dipstick) stored at room temperature from 1 week to 5 years. G genotypes were identical for 21 paired dipsticks and suspensions, whereas dipsticks or suspensions detected an additional G genotype in 2 samples. RNA sequences from 7 pairs were identical. Phylogenetic analysis suggested previously unreported G2 sublineages and G9 lineages. The ease with which dipsticks can be stored at local facilities and transported to central reference laboratories can reverse increasing diffi culties in obtaining geographically representative stool samples and expand surveillance to regions lacking adequate laboratory facilities.
R otavirus infection is a leading cause of gastroenteritis in children <5 years of age worldwide; children with severe dehydration and electrolyte imbalance require hospitalization (1) . In 2007 and 2008, the annual economic cost for hospitalization of rotavirus case-patients in Israel was US $4,578,489 in direct costs to the health system plus an additional household cost of $3,101,955 (2) . Poor hygienic conditions and lack of appropriate medical facilities in developing countries result in high infant mortality rates (1, (3) (4) (5) .
The genes encoding the outer capsid viral proteins VP7 and VP4 form the basis of classifi cation of group A rotaviruses into G and P genotypes, respectively (6, 7) . Two live oral vaccines, monovalent Rotarix vaccine (GlaxoSmithKline, Research Triangle Park, NC, USA) and pentavalent Rotatek vaccine (Merck, Rahway, NJ, USA) effectively reduced hospitalizations for subsequent infections with G1P [8] , G2P [4] , G3P [8] , and G4P [8] rotaviruses by >85% (8, 9) . Rotavirus vaccines that are scheduled for inclusion in Israel's national vaccination program after 2010 may selectively change relative distributions of naturally cocirculating rotaviruses of different G and P genotypes. According to analysis of voluntary immunizations before universal vaccination, the effectiveness of rotavirus vaccine in preventing rotavirus gastroenteritis-associated hospitalizations in Israel is already evident (10) .
Simple to use, inexpensive, diagnostic rotavirus rapid test strips (dipsticks) identify group A rotavirus-positive stools in <30 minutes by lateral fl ow immunochromatography without indicating the genotype. Dipsticks are dipped into saline stool suspensions. If rotavirus is present, a colored band appears when indicator-linked rotavirus antibodies bind to the virus, and this complex is trapped on a band of membrane-bound rotavirus antibody on the dipstick. With their growing use at point-of-care facilities and in local hospital laboratories, fewer samples are available for genotyping by centralized reference laboratories. Obtaining geographically representative stool samples and expanding surveillance to regions lacking adequate laboratory facilities is becoming increasingly diffi cult. The ease with which dipsticks can be stored at local facilities and transported to central reference laboratories can help overcome these diffi culties. We hypothesized that rotavirus trapped on rotavirus-specifi c antibody bands, equivalent to affi nity concentrated rotavirus, might yield genotyping-quality RNA from dipsticks that are easily archived locally and transportable to centralized laboratories. In this study, our main objective was to determine the feasibility of recovering molecular epidemiologic data from rotavirus immobilized on air-dried diagnostic rotavirus dipsticks to compensate for the decreasing number of fecal samples reaching central reference laboratories.
Methods
Stool .) The section of the dipstick containing the rotavirus-specifi c bands from 14 rotavirus-positive dipsticks that had been stored at room temperature for at least 1 week were excised and placed into 120 μL saline.
Rotaviral RNA was extracted from these rotavirusspecifi c bands and from the corresponding saline stool suspensions by using QIAmp Viral RNA Mini kits (QIAGEN, Valencia, CA, USA). RNA amplifi ed from rotavirus-specifi c bands from dipsticks archived at room temperature 5 years earlier was similarly extracted. RNA was amplifi ed by using generic primers for reverse transcription-PCR (RT-PCR) (QIAGEN OneStep RT-PCR kits, QIAGEN) followed by heminested PCR (AmpliTaq Gold, Applied Biosystems, Foster City, CA, USA) with genotype-specifi c primers to identify G and P genotypes as described by Gouvea et al. (11) and Gunasena et al. (12), respectively. RT-PCR products were gel purifi ed (QIAQuick Gel Extraction Kit, QIAGEN) or purifi ed directly (HiPure PCR Product Purifi cation Kit; Roche Applied Science, Indianapolis, IN, USA) from the PCR mix and sequenced by using an ABI PRISM Dye Deoxy Terminator cycle sequencing kit (Applied Biosystems) and the genotype-specifi c primer and common primer from the heminested PCR reaction described. Reaction mixtures were analyzed on Applied Biosystems model 373 DNA automatic sequencing system to confi rm the RT-PCR genotyping results and for phylogenetic analysis.
Sequences of the same genotype were truncated to the longest common length by using the Sequencher program (Genecodes, Ann Arbor, Michigan, USA). Nearest-neighbor phylogenetic trees were constructed from these sequences after the data were bootstrapped 1,000 times with ClustalX (13) . The tree was analyzed by using NJplot (14) . Sequences have been deposited in European Molecular Biology Laboratory/GenBank/DNA Data Bank of Japan under accession nos. FN298858-FN298875, FN582119-FN582124, and HQ174462-HQ174463. Isolate names are linked to their specifi c accession numbers in the online Appendix Table  ( www.cdc.gov/EID/content/17/1/44-appT.htm).
This study was approved by the institutional review board of Chaim Sheba Medical Center (SMC-7606-09). Experiments were not performed on humans. All personal identifi cation was removed from the remnants of fecal samples sent to the National Center for Viral Gastroenteritis for rotavirus analysis. The viral RNA used for this study was obtained from these anonymous samples.
Results
To assess the suitability of RNA extracted from dipsticks for determining the VP7 genotype, we fi rst determined the VP7 G genotype of rotavirus in rotavirus-positive clinical samples from children hospitalized during May 15, 2005-May 15, 2006. Of 311 stool samples, 61 were determined to be rotavirus positive by using diagnostic rotavirus dipsticks. The G genotype and P genotype of RNA in 54 of the 61 samples was determined by the size of the heminested PCR amplifi cation product as described. Mixed infections, e.g., >1 G (6 samples) and P genotypes (2 samples) in the same fecal suspension, were found in 8 (15%) of the 54 positive samples. Taking into account mixed infections, we found G1, G2, G3, and G9 G genotypes in 79%, 5%, 2%, and 15%, respectively, of the 62 rotaviruses identifi ed in the 54 clinical samples. The frequencies of associated G and P genotypes for isolates from the 2005-2006 rotavirus season were 3% G1P [4] , 76% G1P [8] , 5% G2P [4] , 2% G3P [8] , 3% G9P [4] , and 11% G9P [8] .
We chose 18 rotavirus-positive clinical samples with which to study the feasibility of recovering molecular information from dipsticks. Thirteen were from children infected with 1 G genotype of rotavirus and 5 from children simultaneously infected with rotaviruses belonging to 2 different G genotypes. Of the 13 infections by a single G genotype, 8 were G1, 3 were G2, and 1 each were G3 and G9. All 5 mixed infections, RoV-24_ISR05, RoV_41_ISR05, RoV_56_ISR06, RoV_57_ISR06, and RoV_60_ISR06, were simultaneous infections with G1 and G9 genotypes. Mixed infections were identifi ed by specifi c product size on gels and confi rmed by partial sequencing of the G1 product for all 4 patients whose G9 sequences appear in the Figure. RNA was extracted from rotavirus-positive bands of dipsticks from the 18 clinical samples. The dipsticks had been stored for >1 week at room temperature. The quality of the RNA from all 18 extractions was suffi cient to enable determination of VP7 G genotypes by heminested RT-PCR. The genotypes obtained from the RNA extracted from dipsticks were identical to those from RNA extracted from corresponding saline suspensions for 14 of the 18 rotavirus-positive stool samples, including 3 samples from children with dual infections. In 2 mixed G1-G9 infections, G9, but not G1 RNA, was recovered, and G1 RNA was recovered from dipstick RNA in addition to G9 from a G9-infected child. A fourth dipstick from a G3 sample yielded a G3 and an equivocal G1 that did not appear in subsequent replicate heminested amplifi cations. In other words, 21 (92%) of 23 genotypes identifi ed from RNA extracted from 18 fecal suspensions were also identifi ed from RNA extracted from dipsticks, including 8 of 10 genotypes from 5 samples simultaneously infected with rotaviruses of 2 different genotypes.
Rotaviral VP7 RNA suitable for genotyping was also recovered from all 5 air-dried rotavirus-positive dipsticks that had been stored at room temperature for 5 years. The G genotypes of the rotavirus in the fecal suspensions from the 5 archived dipsticks from 2002 were unknown, and the suspensions were no longer available for comparison. One of the dipsticks was manufactured by Hy Laboratories; the remaining 4 were manufactured by Novamed. Initial amplifi cation with generic G-type primers yielded generic G genotype amplifi cation products of expected size (≈1,062 nt) upon gel electrophoresis. Three of the dipsticks yielded G3 RNA; the other 2 yielded G1 RNA. As proof of concept that P genotypes could be determined in addition to G genotypes, the P genotypes of RNA recovered from 2 of the 5-year-old rotavirus dipsticks with G3 RNA were also determined by direct sequencing of the RT-PCR products by using the generic P-type primers. Both were P [8] by sequence analysis (online Appendix Table) . The G genotypes of 3 G1s, 2 G2s, 1 G3, and 1 G9 RNA extracted from dipsticks were confi rmed by sequencing their heminested amplifi cation products. Moreover, the sequences of the RNA extracted from each of the 7 dipsticks were identical to the sequence of the RNA extracted directly from the corresponding stool suspension. The lineages and sublineages of these and other isolates from the 2005-06 season were inferred from phylogenetic comparisons to equivalent segments of the 11 lineages of G1, the 2 lineages of G2, the 4 lineages of G3, and the 6 lineages of G9 described by Phan et al. (15) (18), respectively. The G3 phylogenetic tree also includes 3 sequences obtained from the 5-year-old dipsticks and 4 G3 isolates from among those with highest homology to G3 isolates from Israel identifi ed in BLAST searches (http:// blast.ncbi.nlm.nih.gov/Blast.cgi) (19) . Specifi cally, all VP7 sequences for a given G genotype were aligned and truncated to the longest common segment. Four separate phylogenetic trees (Figure) were constructed because of the size difference between G genotype-specifi c heminested amplifi cation products. The lineage or sublineage of each isolate from Israel (online Appendix Table) was inferred from the relative difference of each sequence compared with equivalent segments of previously determined lineages. For each genotype, a new lineage or sublineage was suggested when the sequence from Israel failed to closely group with the equivalent segment of >1 reference strains and the nucleotide differences between the strain from Israel and the reference strains were similar or greater than the differences among reference lineages and sublineages. The existence of such new lineages and sublineages would need to be confi rmed with longer full-length open reading frame sequences. Finally, sequences from RNA recovered from dipsticks and/or from saline suspensions were used in BLAST searches to identify the most similar contemporary sequences. G1 isolates were most similar to isolates from Europe, the Far East, and South America; G2 isolates to isolates from the Far East; and G3 isolates to isolates from Europe and the Far East (Figure) . G9 isolates were most similar to isolates from Africa, Europe, and the Far East.
Discussion
The G1P [8] (2) , evidence is good for rotavirus reassortants emerging in vivo from appropriate double infections. Phylogenetic analysis in the present study suggested that some G2 and G9 rotaviruses from Israel belonged to new sublineages or lineages, respectively.
In conclusion, air-dried affi nity-concentrated virus from rotavirus-positive bands of dipsticks yielded RNA suitable for G genotyping and sequencing, even for dipsticks stored at room temperature for 5 years. Even though P genotyping and sequencing was performed only on RNA isolated from 2 of the 5-year old dipsticks, it is reasonable to assume that P genotyping and sequencing would have been possible for the rest based on the equivalent quality of the RNA extracted from the dipsticks and RNA extracted from stool suspensions. Thus, dipsticks can be used for recovery of molecular epidemiologic data by reference laboratories from diagnostic tests routinely performed in many clinical laboratories and point-of-care facilities. RNA extracted from these archived dipsticks will enable centralized laboratories to easily recover epidemiologically useful data from the samples of other laboratories and from regions lacking adequate laboratory facilities. In addition, centralized laboratories will be able to assess whether the introduction of universal rotavirus vaccination changed the distribution of rotavirus genotypes associated with severe rotavirus-associated acute gastroenteritis.
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